Skip to contentB
BioCorRx Inc.
B
BICXBioCorRx Inc. Q1 2025 · 10-Q
Revenue$134.90K$134.90K+3,626.5% vs Q1 2024 Net Income-$841.41K-$841.41KN/M vs Q1 2024 EPS Diluted-$0.06-$0.06no prior Q1 2024 on file Operating Income-$937,946N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
Margins · derivedOperating margin-695.3%+26064.2 pt vs Q1 2024
Net margin-623.7%+33541.4 pt vs Q1 2024
ended Mar 31, 2025 · filed May 15, 2025 · 45 d after period end